Nova Eye Medical gains most in near 2-mnths on upbeat Feb. U.S. sales
** Nova Eye Medical's EYE.AX shares rise as much as 19.5%
to A$0.245, marking its biggest intraday pct gain since Jan. 8
** Stock at its highest level since Feb. 9
** Medical technology company posts U.S. sales for Feb. of
$0.99 mln, up 20% from Jan.
** 728,646 shares change hands as of 2345 GMT, vs 30-day
average volume of 567,925 shares
** Stock down 12.3% YTD, as of last close
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment